by irdadmin | Mar 17, 2016 | Financial Markets
Valeant stock is down another 10% today. I’m wondering if some of the Wall Street Journal writers are reading this blog because the WSJ published an article late yesterday in which it reported that VRX could be forced to write-down its goodwill. I published an...
by irdadmin | Mar 15, 2016 | Financial Markets, Market Manipulation
Valeant Pharmaceuticals (VRX) stock has plunged 86% since August 6. The latest plunge occurred today, with the stock losing 51% from its close of $78 yesterday (click to enlarge): The initial triggers were concerns over the Valeant’s drug-pricing policies and...
